Laboratory Products
Expanded Production of Novel COVID-19 Reference Materials Announced
Mar 24 2020
With the rapid global spread of the SARS-CoV-2 virus and the urgent need for reliable diagnostic solutions, LGC’s SeraCare Life Sciences is expanding production of their novel COVID-19 reference materials to include high titre stocks that serve as a valuable tool for diagnostic manufacturers.
Michael Sweatt, Executive Vice President and General Manager, LGC Diagnostics BU, stated: “As a leading provider to the in vitro diagnostic industry, we are keenly aware of the important role that reliable reference materials play in the development of accurate diagnostic tests. Offering our AccuPlex COVID-19 solution in a high titre format enables diagnostic manufacturers to accelerate development efforts through use of concentrated, lot-specific reference material to complete their assay validation activities. Our dedicated team of scientists are expediting production of these stocks, and we anticipate availability in the coming week.”
AccuPlex reference materials, while mimicking wild-type pathogenic viruses, are safe, non-infectious, and replication-deficient. They serve as true, full-process, quality control solutions that challenge the entire diagnostic workflow, making them a valuable alternative to infectious materials.
More information online
Digital Edition
Lab Asia 31.6 Dec 2024
December 2024
Chromatography Articles - Sustainable chromatography: Embracing software for greener methods Mass Spectrometry & Spectroscopy Articles - Solving industry challenges for phosphorus containi...
View all digital editions
Events
Jan 22 2025 Tokyo, Japan
Jan 22 2025 Birmingham, UK
Jan 25 2025 San Diego, CA, USA
Jan 27 2025 Dubai, UAE
Jan 29 2025 Tokyo, Japan